Follicular Adenocarcinoma

This is a type of cancer that develops in the cells that make up the follicles in the thyroid gland, which is located in your neck. It's a specific type of adenocarcinoma.

Condition

What people with Follicular Adenocarcinoma report

Every report comes from a Lived member, sent anonymously.

Have you had Thyroid Surgery for Follicular Adenocarcinoma?

NameHow it went

About Follicular Adenocarcinoma

What It Is

Follicular adenocarcinoma, usually called follicular thyroid cancer or follicular thyroid carcinoma, is a cancer of the thyroid, the butterfly-shaped gland at the front of the neck that makes hormones regulating metabolism. It starts in the follicular cells, the cells that take up iodine and make thyroid hormone. It is the second most common thyroid cancer after papillary cancer, making up about 1 in 10 cases. Together, these two are called differentiated thyroid cancers because their cells still look and behave much like normal thyroid cells. It usually appears as a single lump in the thyroid that causes no symptoms and is often found during an exam or on a scan done for another reason. Unlike papillary cancer, it seldom spreads to lymph nodes in the neck. When it does spread, it tends to travel through the bloodstream to the lungs or bones. Most people do very well with treatment, although the outlook is slightly less favorable than for papillary cancer. The name causes some confusion. The follicular variant of papillary thyroid cancer is a different cancer and is treated as papillary cancer. Oncocytic carcinoma, formerly called Hurthle cell cancer, was once grouped with follicular cancer but is now classed separately.

Causes & Risk Factors

Most follicular thyroid cancers have no identifiable cause. The clearest environmental link is iodine: the cancer is more common in parts of the world where diets are low in iodine, and rates have fallen where iodine has been added to food. In the United States, iodized salt means most people get enough. Radiation to the head or neck in childhood raises the risk of thyroid cancer in general. A small number of cases occur as part of inherited conditions that also affect other organs, such as Cowden syndrome, DICER1 syndrome, Werner syndrome and Carney complex. A family history of thyroid disease, being a woman and having had a goiter (an enlarged thyroid) are also linked to higher thyroid cancer risk. These associations raise the odds but do not mean any one factor caused an individual's cancer.

How It's Diagnosed

Evaluation usually starts with a thyroid lump. An ultrasound shows the nodule's size and features, blood tests check thyroid function, and a fine-needle aspiration biopsy uses a thin needle to draw cells from the nodule for a pathologist to examine. Follicular cancer is unusually hard to confirm before surgery. Its cells look almost identical to those of a follicular adenoma, a common benign growth, so a needle sample cannot reliably tell them apart. A biopsy result is often reported as a follicular neoplasm or as indeterminate, meaning cancer is possible but not proven. Molecular testing of the sample, which looks for gene changes linked to cancer, can help some people judge whether surgery is needed. The diagnosis is usually made only after the nodule is removed, often by taking out half of the thyroid (a lobectomy). A pathologist then checks whether tumor cells have broken through the nodule's capsule (its surrounding wall) or into blood vessels. That invasion is what defines cancer. Its extent matters too: a minimally invasive tumor shows only small areas of capsular invasion, while blood vessel invasion or widely invasive growth carries a higher risk of spread. Staging also takes age into account, with those under 55 generally having a better outlook at the same extent of disease.

Treatment Options

Surgery is the main treatment. Because the diagnosis often comes from a lobectomy, some people need no further operation, particularly when the tumor is small and minimally invasive. When the tumor is widely invasive, shows more extensive blood vessel invasion or has already spread, surgeons usually remove the rest of the thyroid (a completion thyroidectomy). Removing the whole gland also makes follow-up blood tests and scans more reliable. The main surgical risks are hoarseness from irritation or injury to the nerves of the voice box and low blood calcium from damage to the nearby parathyroid glands, which control calcium. Both are often temporary and are less common with an experienced thyroid surgeon. Radioactive iodine therapy, taken as a capsule or liquid, uses the fact that follicular cells absorb iodine. It destroys leftover thyroid tissue and treats cancer that has spread, including to the lungs or bones. It is recommended for higher-risk tumors but not for everyone with minimally invasive disease. Preparation includes raising thyroid-stimulating hormone (TSH), either by pausing thyroid hormone pills or with injections of a lab-made TSH, plus a low-iodine diet for a week or two. Side effects can include salivary gland swelling, dry mouth and taste changes. For a few days afterward, people limit close contact with others, especially children and pregnant people, following the team's radiation safety instructions. After the whole thyroid is removed, a daily thyroid hormone pill, levothyroxine (such as Synthroid), is needed for life. It replaces the missing hormone and can be dosed to keep TSH lower, since TSH can stimulate thyroid cancer cells to grow. When cancer keeps growing and no longer responds to radioactive iodine, targeted drugs called kinase inhibitors, such as lenvatinib (Lenvima) or sorafenib (Nexavar), can slow its growth. They are reserved for advanced disease because side effects such as high blood pressure, diarrhea and fatigue need close monitoring. Surgery or external radiation can also treat painful or troublesome bone or other metastases.

What to Expect

Most people with follicular thyroid cancer are treated successfully, and long-term survival is the usual outcome. In US cancer statistics, people with this cancer are about 98% as likely as people without it to be alive five years after diagnosis. The figure is over 99% when the cancer is confined to the thyroid and about 62% once it has spread to distant organs. Age, how widely the tumor invaded and whether it has spread are the main factors shaping an individual's outlook. Most people go home within a day of thyroid surgery. Those taking levothyroxine have regular blood tests to adjust the dose. Too little hormone leaves people tired and sluggish, while higher doses can cause a rapid or irregular heartbeat and, over years, weaker bones, so the level of TSH suppression is matched to how likely the cancer is to return. Follow-up continues for years because follicular cancer can return, sometimes long after treatment. Thyroglobulin, a protein made only by thyroid cells, becomes a useful tumor marker once the thyroid is gone: a rising level suggests cancer cells may be present. After a lobectomy alone, the remaining thyroid still makes thyroglobulin, so follow-up relies more on neck ultrasound. Neck ultrasound and, when needed, radioactive iodine scans or other imaging complete the monitoring, which becomes less frequent when results stay reassuring. If the cancer returns, further radioactive iodine, surgery or other treatments are often still effective.

When to Seek Help

Arrange a medical visit for a new lump in the neck, hoarseness or voice changes that do not improve, or a persistent sense of pressure or difficulty swallowing. Most thyroid lumps are benign, but they need assessment. After thyroid surgery, contact the surgical team promptly for numbness or tingling around the mouth or in the hands, or muscle cramps or spasms, which can signal low calcium. Also call them about worsening voice changes or mild swelling at the incision. Neck swelling that grows quickly after surgery, or trouble breathing (including severe muscle spasms with difficulty breathing), can mean bleeding or very low calcium and needs 911 or emergency care right away. During follow-up, tell your care team about new bone pain, a persistent cough or a new neck lump, since these can occasionally signal spread or return of the cancer.

Questions to Ask Your Doctor

  1. 1.Did the pathology show a minimally invasive tumor, blood vessel invasion or a widely invasive tumor, and what does that mean for my risk?
  2. 2.Do I need the rest of my thyroid removed, and would radioactive iodine help in my case?
  3. 3.What TSH and thyroglobulin levels are we aiming for, and how often will they be checked?
  4. 4.How long will I need follow-up, and what results would make you look for cancer coming back?
  5. 5.Is there any reason to consider genetic testing for me or my family?

Last reviewed • Oct 2026

Educational content, not medical advice.